Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
-
Arsen Introduces AI-Powered Phishing Tests to Improve Social Engineering Resilience
-
How CNH’s precision technology is helping farmers tackle water scarcity
-
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
-
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
-
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
-
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
-
Transpire Delivers AI-Assisted Story Building with Case Concepts
-
Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.
-
Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail
-
MAG Silver Reports 2024 Annual Financial Results
-
Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value
-
Next Hydrogen Announces Strategic Partnership with Sungrow Hydrogen
-
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
-
Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.
-
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
-
Rapid7 Appoints Three New Board Members
-
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
-
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular
-
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Sin
-
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Transactions in connection with share buyback programme
-
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
-
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc
-
Aller Media expands Agillic across the Nordics
-
Man Group PLC : Form 8.3 - Serica Energy plc
-
MAG Announces Dividend Policy and Inaugural Dividend
-
Brazil Potash Awards Vegetation Management Contract for Autazes Project Site Preparation
-
Man Group PLC : Form 8.3 - Dalata Hotel Group plc
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Montage Gold Achieves Key Construction Milestone at Its Koné Project as Process Plant Concrete Works Commenced
-
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting
-
UTStarcom Reports Unaudited Financial Results for Second Half and Full Year 2024
-
XploraDEX Aims to Transform How Liquidity Works on The XRP Ledger – $XPL Token Presale Now Open!
-
Intermediate Capital Group plc: Notification of Major Holdings (Correction)
-
The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
-
Electra Announces Non-Brokered Private Placement for up to US$3.5 Million
-
Bybit x Block Scholes: Weekly Derivatives Insights Show Drop in Volatility Hedging
-
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
-
Trust Wallet Reaches 200 Million Downloads Milestone
-
The Oncology Institute Announces $16.5 million Private Placement
-
Electra Advances Financing for North America’s Only Cobalt Sulfate Refinery
-
Sono Group N.V. and Merlin Solar Technologies Announce Partnership to Expand Global Solar Solutions
-
Viamedia Acquires LocalFactor to Transform Digital Ad Operations, Unlock Greater Precision, Reach, Efficiency and Results Across Linear TV, Streaming and Digital
-
CLEAR, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations
-
A USD$25 billion public-private Ghana climate futures and socio-economic initiative is agreed

